Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (2): 223-227    DOI: 10.31083/j.ceog.2021.02.2304
Special Issue: Obesity in pregnancy: risks and management
Review Previous articles | Next articles
Obesity, neural tube defects and folic acid—A complex relationship
Gideon Koren1, *(), Yusuf C Kaplan2, 3
1Head of Pharmacology, Adelson school of medicine, Ariel University, and Director, Motherisk International, 40700 Ariel, Israel
2Terafar-Izmir Katip Celebi University Teratology Information, Training and Research Center, 35620 Izmir, Turkey
3Izmir University of Economics Faculty of Medicine, 35330 Izmir, Turkey
Download:  PDF(178KB)  ( 153 ) Full text   ( 13 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Obesity is associated with twofold increased risk of neural tube defects (NTD). Research has repeatedly shown that about 70% of NTD are folic-acid dependent. Yet, there is controversy whether folic acid status is the main determinant of the increased risk of obesity-induced NTD. The rational for this review is to update and discuss the evidence on the link between obesity, folic acid and NTD, in an attempt to shed light on the question whether optimal folic acid dose schedule can mitigate this risk. During pregnancy maternal folate requirements increase by 5–10-fold, as folate is diverted towards the placenta and fetus, as well as supporting different maternal organs. Correspondingly, low maternal folate status has been associated with birth defects in fetal anatomical regions particularly sensitive to reduced folate intake including oral cleft, cardiovascular defects and NTD. A recent study has documented decreased placental folate transporter expression and activity in the first and second trimesters among obese mothers. This may explain the higher incidence on NTD in infants of obese women, as less folate may find its way to the developing fetus during the sensitive periods for creating NTD. Recent pharmacokinetic results indicate that steady state levels of folate are almost perfectly defined by the dose per lean body weight (LBW). The mean dose per kg LBW that would be expected to result in steady state serum folate level of > 15.9 nmol/L was identified as 0.0073 mg/kg LBW. A large study found no differences in dietary supplementations of folic acid, yet obese women exhibited lower median serum folate as well as lower mean serum B12 levels, but no differences in mean RBC folate levels. There was a negative correlation between increasing BMI and both serum folate and plasma B12. Future research will be needed to incorporate more fully, in addition to evidence of NTD, obesity and folic acid intake, also direct measurements of serum and RBC folate, as well as other confounders, in order to create a model that will shed light on these complex interactions.
Key words:  Obesity      Pregnancy      Folic acid      Neural tube defects      Spina bifida      Congenital abnormalities     
Submitted:  23 September 2020      Revised:  08 November 2020      Accepted:  09 December 2020      Published:  15 April 2021     
*Corresponding Author(s):  Gideon Koren     E-mail:  gidiup_2000@yahoo.com

Cite this article: 

Gideon Koren, Yusuf C Kaplan. Obesity, neural tube defects and folic acid—A complex relationship. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 223-227.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.02.2304     OR     https://ceog.imrpress.com/EN/Y2021/V48/I2/223

[1] Jia-Hui Wu, Dan-Ni Yang, Li-Juan Cao, Jia-Qi Luo, Wei-Ping Qian, Wen-Min Ma, Xi Xia. The effect of oral vitamin E supplementation on infertile women: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 216-222.
[2] Yi Zhou, Ran Wang, Shi-Xian Chen, Li-Sheng Wu, Jun-Qing Zhu. Matrix metalloproteinase 9 gene promoter region -1562 C/T single nucleotide polymorphism increases the susceptibility to hypertensive disorders of pregnancy: a meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 245-252.
[3] Seda Akgün Kavurmacı, Ayşegül Gülbahar. Physical trauma etiologies in pregnancy in Turkey[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 292-298.
[4] Sotirios Sotiriou, Maria Satra, Dimitra N. Vamvakopoulou, Chrisostomos Sofoudis, Aikaterini Simou, Thomas Kilindris, Andreas Sidiropoulos, Konstantinos V. Kakavas, Antonis Garas, Hara Skentou, Nikos C. Vamvakopoulos, Alexandros Daponte. Maternal serum pregnancy-associated plasma protein-A concentration at 11–14 weeks of gestation of women with common congenital anatomic uterine abnormalities[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 343-346.
[5] Sahar H. Abdulghani, Lana A. Shaiba, Mahdya A. Bukhari, Muhab M. Hindi, Shaikh A. Hussain, Adnan A. Hadid. Consequences of SARS-CoV-2 disease on maternal, perinatal and neonatal outcomes: a retrospective observational cohort study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 353-358.
[6] Jun Xiong, Fen Fu, Wei Zhang, Ji Luo, Yuan-Yuan Xu, Lu-Lu Le, Xiao-Ju He. Study on influencing factors and related clinical issues in cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 365-371.
[7] Xiao-Hua Li, Jian-Kun Zhou, Jing-Dan Cheng. Application of ultrasound in hepatic pregnancy: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 434-438.
[8] Mahvash Zargar, Razieh Pazhouhanfar, Mahin Najafian, Parastoo Moradi Choghakabodi. Effects of intrauterine autologous platelet-rich plasma infusions on outcomes in women with repetitive in vitro fertilization failures: a prospective randomized study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 179-184.
[9] Saipin Pongsatha, Theera Tongsong. Intravaginal misoprostol versus sublingual misoprostol for second trimester pregnancy termination: a randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 122-127.
[10] Eman A. Elhosary, Mahmoud M. Ewidea, Marwa A. Mohamed. Efficacy of kinesio tape on neck pain and functional disability in pregnant women: a randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 175-178.
[11] Xiao-Cen Niu, Li-Hua Zhu, Zhi-Da Qian, Li-Li Huang. Disseminated intravascular coagulation developed after suction curettage in an adenomyosis patient: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 189-193.
[12] Khac Tu Chau, Minh Tam Le, Doan Tu Tran, Vu Quoc Huy Nguyen. Uterine torsion in a 25-week pregnant female with congenital uterine didelphys and intraoperative complication of uterine atony: a report of a rare clinical case[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 185-188.
[13] Ji Eun Park, Ji Kwon Park, Hyun Chul Jo, In Ae Cho, Jong Chul Baek. The association between antenatal corticosteroid use in late-preterm and early-term pregnancy and nonreassuring fetal status[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 79-84.
[14] Jing-Jing Jiang, Ting Han, Yan-Hui Zhu. The early second-trimester multifetal pregnancy reduction improves pregnancy outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 164-167.
[15] Sureyya Saridas Demir, Erkan Cağliyan, Sabahattin Altunyurt. Retrospective analysis of pregnancy terminations and indications in a tertiary center[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 85-90.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .
[9] Dean J. Kereiakes. Coronary Small-Vessel Stenting in the Era of Drug Elution[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 34 -45 .
[10] Steven V. Edelman. The Role of the Thiazolidinediones in the Practical Management of Patients With Type 2 Diabetes and Cardiovascular Risk Factors[J]. Reviews in Cardiovascular Medicine, 2003, 4(S6): 29 -37 .